We examined the pattern of fibulin-1 mRNA and protein expression in human tissues and cell lines. Fibulin-1 transcripts were found in RNA isolated from most tissues and a variety of cultured cells, including fibroblasts, smooth muscle cells, and several epithelial cell lines, but not endothelial cells, lymphomyloid cells, or a number of carcinoma and melanoma lines. Immunohistochemical analysis showed that fibulin-1 is an intercellular component of connective &sues, predominantly associated with matrix fibers in tissues such as the cervix, dermis, intimal and medial layers of blood vessels, heart valves, meningeal tissue of the brain, Wharton's jelly of the umbilical cord, testis, and lung. Most of the fibers that were immunoreactive with fibulin-1 antibodies also stained with antibodies to the elastic fiber proteins elastin * Correspondence to: W. Scott Argraves, Biochemistry Dept., J. H. Holland Laboratory, American Red Cross, 15601 Crabbs Branch Way, Rockville. MD 20855. and fibrillin, as well as with Verhoeff's elastin stain. Immunoelearon microscopic analysis of elastin fibers of skin and saphenous vein revealed that fibulin-1 was located within the amorphous core of the fibers, similar to elastin, but it was not in the fibrillin-containing, elastin-associated microfibrils. Our finding that fibulin-1 is an elastic fiber component suggests several possible new functions for fibulin-1, e.g., that it is a structural protein that contributes to the elastic properties of connective tissue fibers or that is involved with the process of fibrogenesis. (J Histochem Cytochem 43: 4014'11, 1995) 
Introduction
The fibulins are an emerging family of extracellular matrix and blood glycoproteins. At present there are two distinct members of the family, designated fibulin-1 (Pan et al., 1993a; Argraves et al. 1990; Kluge et al., 1990) and fibulin-2 (Pan et al., 1993b) . The fibulins are structurally similar proteins containing repeated structural elements such as anaphylatoxin-like elements and EGF-like modules. Alternative splicing of fibulin-1 precursor RNA results in four transcripts that encode polypeptides differing from one another only in their carboxy terminal regions. The four fibulin-1 polypeptides are designated A-D and have core proteins with calculated molecular masses (lacking substitutions) of 58, 62, 71, and 74 KD, respectively (Pan et al., 1993a; Argraves et al., 1990) .
Fibulin-2 is larger, having a core protein molecular mass of 142 KD (Pan 1993b) . The higher molecular mass of fibulin-2 is due Supported by NIH grants GM42912 (WSA), H637709 (CDL), and by the Shriners Hospital for Crippled Children. EFR was a recipient of an Individual National Research Service Award HD07515 from NICHHD. in part to its unique 402-residue amino terminal domain not present in fibulin-1 and its possession of two more EGF-like modules than fibulin-1. Fibulin-1 binds calcium (Kluge et al., 1990; Argraves et al. l989) , possibly through EGFlike modules bearing 0-hydroxylated asparagine or aspartic acid residues (Argraves et al., 1989) . S-Hydroxylated residues are present in the metal-binding EGF-like elements of proteins such as coagulation factor X (Sugo et al., 1984) and protein C (Ohlin et al., 1988) . Fibulin-2 is expected to be a calcium-binding protein because it, too, has EGFlike modules that contain the consensus hydroxylation sequence. Fibulin-1 self-interacts and binds fibronectin (Balbona et al., 1992) . laminin, and nidogen in vitro (Pan et al., 1993a) . The physiological significance of these interactions remains to be established. However, fibulin-1 has been demonstrated to co-localize with fibronectin in ECM fibrils produced by cultured cells, and it is a component of basement membranes that contain laminin and nidogen.
The expression of fibulin-1 mRNA and protein has been examined in mouse tissues (Kluge et al., 1990) and in chicken and mouse embryos (Zhang et al., 1993; Spence et al., 1992) . Fibulin-2 expression in mouse tissues has recently also been described (Pan et al., 1993b) . Transcripts encoding murine fibulin-1 and -2 are expressed in brain, spleen, lung, skeletal muscle, kidney, liver, testis, and at high levels in heart (Pan et al., 1993b) . Immunohistological analysis of mouse tissues has revealed that fibulin-1 is present in Reichert's and Descemet's basement membranes, lens capsule, Engelbreth-Holm-Swarm (EHS) tumor, and endomysium surrounding skeletal muscle cells (Kluge et al., 1990) . Fibulin-2 has been immunologically detected in many of the same mouse tissues as fibulin-1, e.g., the basement membranes of the cornea, surrounding muscle fibers, and glomeruli. However, fibulin-2 was detected at several sites in which fibulin-1 was not, e.g., the keratinocyte layer of epidermis, small renal vessels, and liver portal veins. A major difference in expression of the two fibulins is seen in blood, where fibulin-1 is 1000-fold higher in concentration than fibulin-2 (Pan et al., 1993a) . During embryonic development, fibulin-1 has been detected at sites of epithelial-mesenchymal transitions such as endocardial cushions, developing myotomes, and neural crest (Zhang et al., 1993; Spence et al., 1992) and in many basement membranes, including those of ectoderm, foregut endoderm, splanchnic mesoderm, and notochord (Spence et al., 1992) .
Our present understanding of the in vivo expression of fibulin-1 is limited to information derived from studies of mouse and chicken tissues. The pattern of fibulin-1 expression in human tissues has not been described. In this study we examined the expression of both fibulin-1 mRNA and protein in a number of human tissues and cultured human cell lines.
Materials and Methods
Antisera. Mouse monoclonal fibulin-1 antibody 6D8 (MAb 6D8) was produced as described in Argraves et al. (1990) and its epitope was mapped to the amino terminal region of fibulin-1 (data not shown RNA Analysis. RNA was isolated from cultured cell lines with guanidinium thiocyanate, followed by centrifugation in cesium chloride solution according to methods described in Sambrook et al. (1989) . Tissue RNAs were purchased from Clontech (Palo Alto, CA) and used to prepare cDNA using reverse transcriptase and random primers as described previously (Argraves et al., 1990) . Cell line RNA was analyzed by Northern blot RNA hybridization, but because the amounts of tissue RNAs were limiting, reverse transcriptase PCR (RT-PCR) analysis was used, with both approaches done as described in Argraves et al. (1990) . The probe used for RNA hybridization analysis was a 2.2 KB human fibulin-1C cDNA (Argraves et al., 1990) . For RT-PCR analysis, cDNA templates made from tissue poly A' RNA were combined with the following oligonucleotide prhers from human fibulin-1: CCCGGAGl'GGACGCGGAETCCTCC (residues 84-107) and CCTCCAGCTGGCE'IGGCAGCACT (residues 210-233). The following parameters were cycled 35 times for RT-PCR 1 min at 94'C, 2 min at 50'C, and 3 min at 72'C. Control reactions were performed using aliquots of RNA to which no reverse transcriptase had been added.
Tissues. Human saphenous vein and heart valve tissues were obtained from Dr. Carl Trible (Department of Surgery, U. of Virginia, Charlottesville, VA). Adult human skin, kidney, and lung specimens were obtained from the Cooperative Human Tissue Network (Columbus, OH). Human neonatal foreskin, placenta, and placental umbilical cord were obtained from Montgomery General Hospital (Olney, MD).
Immunohistochemistry. Tissues were fixed for 18 hr at room temperature (RT) with methacarn (Puchtler et al., 1970) . (60% methanol, 30% chloroform, 10% acetic acid). After fixation the tissues were placed in 70% ethanol overnight at 4'C. then embedded in paraffin and sectioned at >-pm thickness. Tissues sections were deparaffinized with xylene and graded ethanol. Immunohistochemical staining was done with reagents supplied in the Vectastain ABC kit (Vector; Burlingame, CA), including horseradish peroxidase-conjugated anti-antibodies and the chromogenic substrate DAB. All the steps in the staining process were automated using a Code-On Immuno/DNA Slide Stainer (Instrumentations Laboratory; Indiana, PA). Sections were subjected to Verhoeff's van Gieson staining or counterstained with Mayer's hematoxylin and eosin Y according to methods detailed in Luna (1968) .
Section Surface Immunocytochemistry and Electron Microscopy. Human skin was obtained from a 12-year-old boy, trimmed into small pieces, and immersed in ice-cold cacodylate-buffered 0.1% glutaraldehyde, pH 7.4, for 30 min. After a brief buffer rinse, the tissue was rinsed several times in 0.15 M 'Itis-HC1 over a 16-h period at 4°C. then dehydrated in a graded series of ethanol concentrations (30-100%). After infiltration in Lowicryl K4M (Electron Microscopy Sciences; Fort Washington, PA), samples were flat-embedded and polymerized under uv light for several days in a CO2 atmosphere at -20°C. Polymerization was continued for several more days at RT until the resin had a slightly yellowish tinge.
Human saphenous veins were taken from patients undergoing coronary bypass surgery, fixed in methacarn at RT for 18 hr, and transferred to 70% ethanol. Dehydration was continued on ice for 15 min in ice-cold 90% ethanol, then 95% ethanol, and for 30 min in ice-cold 100% ethanol. Samples of vein were then infiltrated, embedded in Lowicryl K4M, and polymerized as described above for skin.
Ultra-thin sections were cut with a Reichert Ultracut E microtome and mounted on 1 x 2-mm single-hole formvar-coated slot grids. Immunolabelings of the section surfaces were performed as described previously (Sakai et al., 1986) with some modifications. Briefly, grids were floated, section surface down, for 15 min in twice-distilled water (ddH20) and then for an equal time in 5% normal goat serum in PBS containing 2% non-fat milk (Carnation). The grids were then transferred onto the surface of PBS for 5 min, then onto a pool of primary antibody (MAb 6D8, MAb 10B8, or polyclonal fibrillin antibody 7075) diluted 1:3 in PBS. After 2 hr the samples were floated onto the surface of PBS for 10 min, then submerged in several changes of ddH20. The non-section surfaces of the grids were dried and the grids again deposited section surface down onto a pool of 10-nm gold conjugated to goat anti-mouse or goat anti-rabbit IgG (Amersham; Poole, UK), whichever was appropriate for the species of primary antibody. After an 80-min incubation at RT the grids were again floated on a pool of PBS and then immersed in ddH20 as described above. Sections were dried and examined either unstained or after staining for 15 min in a saturated solution of uranyl acetate in 50% ethanol and Reynolds' lead staining (Reynolds, 1963) .
En Bloc Immunoelectron Microscopy. Skin from a clinically diagnosed sun-damaged region of the face (a 74-year-old woman) was either fixed for 30 min in ice-cold 0.1% glutaraldehyde or placed directly in antibody without fixation. Fixed samples were rinsed in PBS for 15 min. then rinsed overnight in several changes of cold 0.15 M Xis-HCI. Both fixed and unfixed specimens were submerged in primary antibody (MAb 6D8) diluted 1:5 in PBS for 16 hr at 4%. After several changes of PBS over a 6-hr period. the specimens were submerged in PBS containing goat anti-mouse IgG conjugated to 1-nm gold (Amersham) for 16 hr and then washed extensively with PBS. To enhance the visualization of small gold particles, silver was precipitated onto their surfaces by a procedure described previously (Rousselle et al., 1991). The specimens were then rinsed in 0.1 M cacodylate buffer, pH 7.4, and fixed in thesame buffer containing 1.5% glutaraldehyde/l.>% paraformaldehyde for 1 hr at 4°C. All samples were dehydrated, exposed to propylene oxide, and embedded in Spurrs epoxy resin as described (Sakai et al., 1986) .
Results

Fibulin mRNA Expression in Tissues una' Cultured Cell Lines
RT-PCRs were performed using fibulin-1 specific oligonucleotide primers and cDNA templates made from RNA isolated from various human tissues. The expected size amplification product was generated from all the tissue cDNA preparations (Eble 1). No products were obtained by using the cDNA preparations and the individual primers alone or by using template to which no reverse transcriptase was added. The results indicate that fibulin-1 mRNA was expressed in all the tissues tested. However, lower amounts of the PCR product were seen with kidney and liver templates relative to that the other tissues.
RNA hybridization analysis was performed on total RNA isolated from various types of cultured human cell lines. The results are summarized in Table 1 . Fibulin-1 mRNA was detected in RNA from fibroblast lines, smooth muscle cells, and a number of epithelium-derived lines. However, it was not detected in RNA from endothelial cells, lymphomyeloid cells such as peripheral blood monocytes, or in a number of colon carcinoma and melanoma lines.
The level of fibulin-1 mRNA in the SV-40-transformed WI-38 line VA-13 was no different from that in normal WI-38 cells. and no fibulin-1 mRNA was detectable in RNA preparations from either young or senescent human umbilical vein endothelial cell cultures. Two fibulin-1 mRNAs, corresponding to the 2.4 KB C and 2.7 KB D alternatively spliced transcripts, were the predominant fibulin-1 mRNAs expressed in cultured cells (always in equal stoichiometry), with no A and B transcripts detected (data not shown).
Immunohistochemical Detection of Fibulin-1 in Human Tissues
Using monoclonal fibulin-1 antibodies, we examined a number of human tissues and found fibulin-1 to be widely distributed. The is associated with connective tissue elastic fibers that contain elastin and have associated microfibrils that contain fibrillin. In adult skin, fibulin-1 staining was apparent in epidermal cells ( Figure 1A) with a relatively high degree of staining in basal layers. The inner and outer epithelial layers of hair follicles and the epi-thelial cells of sebaceous glands showed strong fibulin-1 staining. In the dermis, an extensive network of fibulin-1-immunolabeled fibers was apparent. In separate double-label immunofluorescence staining experiments using antibodies to fibulin-1 and elastin (MAb 10B8 or HAE-l), double staining of dermal fibers was seen (data not shown). However, there were some elastin-immunoreactive fibers that did not stain with fibulin-1 antibodies. Strong fibulin-1 staining that resembled a basement membrane staining pattern was seen in the junctional region, but because basal cell staining was also strong it was difficult to determine unequivocally if fibulin-1 was a basement membrane constituent. No fibulin-1 staining was apparent in regions of capillary basement membranes. The distribution of fibulin-1 in neonatal foreskin was distinct from that of adult abdominal or scalp skin. For example, little or no fibulin-1 staining was apparent in neonatal foreskin epidermis or in the epidermal-dermal junction region ( Figure IC) , whereas the dermis showed diffuse staining of fine fibers. Smooth muscle cells of dermal arrectores pilorum and foreskin dartos layer ( Figure ID) also stained with fibulin-1 antibodies.
In lung, fibulin-1 staining was very pronounced in connective tissue elastic fibers subjacent to bronchiolar mucosa (Figure 2A) , in the plexus of fibers of the alveolar wall ( Figure 2B) , and in pulmonary blood vessels ( Figure 2C) . Bronchiolar smooth muscle cell bundles were also positive for fibulin-1. No staining of bronchiolar ciliated epithelial cells, goblet cells, or alveolar epithelial cells (Types I and 11) was apparent, but some alveolar macrophages displayed strong intracellular staining.
Fibulin-1 staining was evident in medial layers of virtually all blood vessels, including pulmonary arteries and veins, renal arteries and veins, aorta, coronary artery, and intramural arteries and veins. Figures 3A-K show fibulin-1 staining in saphenous vein, which was typical of the staining seen in other vessels. Pronounced fibulin-1 immunostaining was diffusely deposited surrounding smooth muscle cells of the medial layer. Although fine pericellular fibers surrounding smooth muscle cells were seen to stain with fibulin-1 antibodies, coarse fibers, present in the adventia and lamina and reactive with elastin antibody and Verhoeff's van Gieson, did not stain with fibulin-1 antibody. Consistent with the observed absence of fibulin-1 mRNA in cultured endothelial cells, no fibulin-1 staining was evident in vascular endothelium except for small venules and capillaries in the tonsil. In muscular arteries, the internal and external elastic lamellae stained strongly with antibodies to fibulin-1 ( Figure 2C ), elastin ( Figure 2R ), and fibrillin (Figure 20) .
Granular intracellular staining was also apparent in many cell types, including renal proximal and distal tubule epithelial cells, hepatocytes, neurons, Leydig cells, fibroblasts, alveolar macrophages, syncytial trophoblasts, and smooth muscle cells. The granular pattern of intracellular staining may correspond to fibulin-1 in secretory or endocytic vesicles. The vesicle-like deposition of fibulin-1 was perhaps best seen in hepatocytes and epithelial cells of renal tubules.
Electron Microscopic Immunolocalization of Fibulin-1
Immunolocalization studies of fibulin-1 were performed on the surfaces of sections cut from 12-year-old skin and adult saphenous vein and were examined by electron microscopy. In both skin and saphenous vein, fibulin-1 MAb directed gold deposition to the cores of elastin fibers ( Figures 4A and 4B) , although not all fibers were clustered over electron-dense islands that seemed uniformly spaced throughout the core. No labeling of microfibrils surrounding the elastin cores or interstitial collagen fibers was apparent. Elastin antibodies also directed gold particle deposition to the amorphous cores of elastic fibers ( Figure 4C ) but did not label microfibrils surrounding either elastin cores or those close to the epithelial basement membrane. By contrast, fibrillin antibodies directed gold particle deposition over all microfibrils in skin ( Figure 4D ), including those in the immediate vicinity of the epithelial basement membrane (not shown).
In experiments performed with sun-damaged skin, small blocks of tissue were soaked in primary and secondary antibodies, relying on diffusion to carry the antibodies to their respective binding sites. Many of the elastic fibers of sun-damaged skin appeared swollen or had many open areas within the cores of the fibrils. Consistent with results from section surface staining, fibulin-1 MAb directed gold particles to the interior of the elastic fibers (Figure 5 ) . Immunogold labeling of microfibrils was exceptionally rare. Elastin antibody produced an almost identical labeling pattern to that of fibulin-1 (not shown). The use of antibodies to fibrillin however, resulted in a preponderance of labeling of the associated microfibrils and an absence of label within the elastin cores. The data from immunoelectron microscopy confirm the immunohistochemical data indicating that fibulin-1 was a component of elastic fibers and, in addition, demonstrate the presence of fibulin-1 in the amorphous cores of such fibers, along with elastin.
Discussion
The aim of this study was to examine the pattern of expression of fibulin-1 in tissues and cultured cells to gain insight into the biological function of this recently discovered protein. Perhaps one of our most intriguing findings was that connective tissue elastic fibers are immunoreactive with fibulin-1 antibodies. Elastic fibers are abundant in tissues that undergo reversible deformation, such as blood vessels, lung, and skin, and are in large part responsible for the elastic properties of these tissues. By immunoelectron microscopy, fibulin-l was localized to the inner amorphous cores of elastic fibers in skin and blood vessel walls. The fact that cores of elastic fibers also contains elastin suggests a potential for interaction between the two proteins. However, interaction with any of a number of microfibril proteins that penetrate into the core is passible. It is important to point out that we did not detect fibulin-1 in all elastin fibers. For example, coarse fibers within the tunica media and tunica adventitia of saphenous vein stained with elastin antibodies and Verhoeff's van Gieson-elastin stain but did not stain with fibulin-1 antibodies. Furthermore, double-label immunofluorescent staining of adult skin revealed that some fibers were immunoreactive with elastin antibodies but not with fibulin-1 antibodies. Although an antigen-masking phenomenon might explain these results, we cannot rule out that fibulin-1 may be associated with a subset of elastin-containing fibers.
The molecular composition of elastic fibers is complex, with an array of proteins associated with specific aspects of the fiber architecture. For example, proteins such as fibrillin (Sakai et al., 1986) and microfibril-associated glycoprotein (Gibson et al., 1986) associate with the microfibrils that coat the fibers, emilin (Bressan et al., 1993) associates with the fiber-microfibril interface, and elastin (Parks et al., 1993) and fibulin-1 are found in the amorphous core. The functional significance of fibulin-1 as an elastic fiber core constituent remains to be established. One possibility is that fibulin-1 serves a structural role, perhaps acting to stabilize the fibers through lateral interactions with elastin molecules or with components of microfibrils that both coat elastic fibers and penetrate into their cores. A second possibility is that fibulin-1 plays a role in elastic fibrogenesis. Relatively little is known about the role of other elastic fiber constituents in the formation of elastic fibers. Microfibrils are thought to act as a scaffold for the deposition of elastin and to direct elastic fiber orientation (Cleary and Gibson, 1983) . Kagan et al. (1986) have proposed that elastic fiber assembly is a multistep process initially involving microfibril deposition followed by binding of lysyl oxidase, the enzyme that crosslinks tropoelastin, and finally the deposition and cross-linking of elastin within the microfibril-enzyme aggregates. In this regard, it is interesting that fibulin-1 has been detected in various embryonic tissues of chicken (Spence et al., 1992) and mouse (Zhang et al., 1993) at stages that precede the expression of tropoelastin in those areas. For example, fibulin-1 has been immunologically detected in heart splanchnic mesoderm as early as Stage 9 and in the mesocardium at Stage 10 (Spence et al., 1992) , whereas the earliest that tropoelastin has been detected during avian embryogenesis was at Stage 21-22, in which it was observed in the wall of outflow tract vessels (Holzenberger et al., 1993; Rosenquist et al., 1988) . The microfibril constituent fibrillin is expressed similarly to fibulin-1, since the former has also been detected in Stage 10 mesocardium (Gallagher et al., 1993) . It is possible that fibulin-1 works in conjunction with microfibril components such as fibrillin to act as a nidus for elastic fiber formation or even to direct microfibril deposition.
The significance of the presence of fibulin-1 in some basement membranes (Spence et al., 1992; Kluge et al., 1990) and in elastic fibers is not clear. It is possible that the ability of fibulin-1 to bind components of basement membranes such as laminin and nidogen (Pan et al., 1993a) and its ability to associate with elastic fibers serves to connect or anchor these structural elements. This is perhaps illustrated in adult skin, in which pronounced fibulin-1 staining was seen in the dermal-epidermal junction and in the elastic fibers of the reticular region. The dermal-epidermal junction was largely devoid of elastin staining. Conceivably, fibulin-1 could serve to bridge this region and make connections between the basement membrane and dermal elastin network. This may require that fibulin-1 associate with other fibrillar elements in this region such as fibronectin. However, fibulin-1 can self-associate in vitro (Balbona et al., 1992) , and recent electron micrographs of rotaryshadowed fibulin-1 show various types of ordered multimers (unpublished observations), suggesting an ability to oligomerize.
Several plasma proteins, including vitronectin, serum amyloid P, and complement components, have been reported to associate with elastic fibers increasingly with age (Dahlbach et al., 1989; Breathnach et al., 1981) . The biological significance of the association of these proteins with elastic fibers is not understood. Fibulin-1 is also a plasma protein present at 30-50 pg/ml in blood (Argraves et al., 1990) . Although it is possible that plasma fibulin-1 becomes associated with elastic fibers, fibulin-1 staining was consistently found within cells in the vicinity of fibers, suggesting that is expressed within the tissues. In situ RNA analysis will be required to confirm this and to determine the exact cell types in connective tissues that express fibulin-1. However, fibulin-1 RNA is exprkssed in culture by many types of cells, such as fibroblasts and smooth muscle cells, that are typically found in the vicinity of elastic fibers in vivo.
The fact that fibulin-1 is found in association with elastic fibers may have implications for heritable connective tissue disorders that involve these fibers (Uitto et al., 1991) . The list of such disorders includes pseudoxanthoma elasticum, cutis laxis, Buschke-Ollendorff syndrome, Debarsy syndrome, wrinkly skin syndrome, elastoderma, supravalvular aortic stenosis (SVAS), and Marfan syndrome. SVAS has been linked to the gene encoding the elastic fiber protein elastin (Curran et al., 1993) and Marfan syndrome to the gene encoding the elastin fiber-associated microfibril protein fibrillin (Dietz et al., 1991) . It is possible that mutations in the fibulin-1 gene lead to abnormal phenotypes that resemble any of the above-mentioned disorders. We have recently mapped the chromosomal localization of the fibulin-1 gene to 22q13.3 (Korenberg et al., 1995) . and this should aid in evaluation of its potential role in heritable connective tissue diseases.
